Tasectan® AF
Product Description
Noventure
-
Country/Region:Spain
-
Founded:2001
-
On CPHI since:2024
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
Categories
Specifications
Noventure
-
Country/Region:Spain
-
Founded:2001
-
On CPHI since:2024
-
Certificates:2
-
Employees:1 - 24
Company types
Primary activities
More Products from Noventure (2)
-
Product Tasectan® AF Kids
Tasectan® AF is a substance-based medical device composed of xyloglucan (tamarind seed extract) and gelose. This combination acts by forming a film that protects the intestinal mucosa, reducing the frequency and duration of diarrhoeal episodes. The therapeutic effects of the device start from 6 hours after... -
Product Utipro® Plus AF
Utipro® Plus AF is a medical device based on xyloglucan and gelose.
It acts mechanically in the intestinal lumen, impairing the contact of the pathogens with the intestinal mucosa, which is the first step for bacterial proliferation and their subsequent passage to the urinary tract.
Noventure resources (2)
-
News New publication for UTIPRO® PLUS / UTIPRO® PLUS AF (The UTISWISS Study)
We are happy to announce the publication of new evidence on the benefit of an antibiotic-free approach (xyloglucan, hibiscus and propolis for oral administration) in the management of uncomplicated urinary tract infections. -
News Tasectan and Xilaplus in the new German GPGN Guidelines
Z Gastroenterol 2024; 62(09): 1574-1643
Getting into treatment guidelines is lengthy, especially for new products that need time to gather sufficient scientific and real-life evidence.